Erythrocyte Transport of Lactate During Exercise (TELE Project)
TELE
Transporte Eritrocitario de Lactato en Ejercicio
1 other identifier
interventional
84
1 country
2
Brief Summary
The goals of this clinical trial are:
- In phase I, trained participants will perform one maximal incremental test and one intervallic submaximal test with a final active recovery.
- Phase II, levels of the MCT1 protein in the erythrocyte membrane will be quantified from trained and sedentary participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2020
CompletedFirst Submitted
Initial submission to the registry
October 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
September 12, 2025
September 1, 2025
7.4 years
October 19, 2023
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Plasma-Erythrocyte lactate difference
Difference between lactate concentration inside the erythrocytes and lactate concentration in plasma, expressed in mMol/L (Millimoles Per Liter), from venous blood extracted during the intervallic test from the antecubital vein.
Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Level of Monocarboxylate Transporter 1 in erythrocytes membrane
Protein abundance of the monocarboxylate transporter 1 in erythrocyte membranes. It is measured using flow cytometry, from venous blood extracted from the forearm in rest state.
Through study completion, average of 5 years, an average of 2 months per participant
Secondary Outcomes (4)
Erythrocyte lactate concentration
Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Plasma lactate concentration
Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Blood lactate concentration
Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Blood pH
Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Other Outcomes (2)
Genotype for the rs1049434 polymorphism of the SLC16A1 (MCT1) gene
Through sample recruitment, average of 5 years, an average of 1 month per participant
Physical Activity level
Through sample recruitment, average of 5 years, an average of 1 month per participant
Study Arms (1)
Intervallic submaximal test
EXPERIMENTALIntervallic exercise test
Interventions
Intervallic submáximal exercise test on a cycle ergometer: 5 min warm-up at 80% of First Lactate Threshold (LT1), and subsequent sets of 1.5 min at 20% above the Second Lactate Threshold (LT2) alternated with recoveries of 5 min at 80% of LT1, ending with a 20 min recovery at 80% of LT1.
Eligibility Criteria
You may qualify if:
- BMI between 18 and 25 kg/m2
- Not smoker
- In the case of trained participants: training at least 5 hours/week, of which at least 3 must be aerobic/anaerobic endurance training. Presentation of a medical certificate attesting to their medical fitness (capability) to perform intense physical exercise.
- In the case of sedentary participants, less than 1 day of training per week or less than 2 hours of structured exercise per week.
You may not qualify if:
- Presenting any pathology that could impede the correct performance of the tests, or could influence the main study variables.
- In the case of the female sample, having irregular menstrual cycles, oligomenorrhea or amenorrhea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Laboratorio de Pediatría. School of Medicine. Univesidad de Cantabria
Santander, Cantabria, 39011, Spain
Laboratorio de Fisiología del Esfuerzo. Facultad de Ciencias de la Actividad Física y del Deporte (INEF). Universidad Politécnica de Madrid
Madrid, Madrid, 28040, Spain
Related Publications (1)
Benitez-Munoz JA, Rojo-Tirado MA, Benito Peinado PJ, Murias JM, Gonzalez-Lamuno D, Cupeiro R. Greater Relative First and Second Lactate Thresholds in Females Compared With Males: Consideration for Exercise Prescription. Int J Sports Physiol Perform. 2024 Oct 28;20(1):30-36. doi: 10.1123/ijspp.2024-0079. Print 2025 Jan 1.
PMID: 39467538DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rocío Cupeiro, PhD
Universidad Politecnica de Madrid
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Activity and Sports PhD (Associate Professor)
Study Record Dates
First Submitted
October 19, 2023
First Posted
October 27, 2023
Study Start
February 3, 2020
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
September 12, 2025
Record last verified: 2025-09